Skip to content

Sequential method was used to determination of median effective dose of Oliceridine in inhibiting tracheal intubation response in patients with general anesthesia under propofol sedation

Sequential method was used to determination of median effective dose of Oliceridine in inhibiting tracheal intubation response in patients with general anesthesia under propofol sedation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082467
Enrollment
Unknown
Registered
2024-03-29
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reaction during tracheal intubation

Interventions

Oliceridine group:Give a certain dose of Oselidine

Sponsors

Chongqing University Fuling Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ( 1 ) 18 = age = 60 years old, ASA I-II, 18kg / m2 = BMI = 28kg / m2, regardless of gender; ( 2 ) Patients undergoing surgery under general anesthesia with tracheal intubation and mechanical ventilation; ( 3 ) Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: ( 1 ) Known to be allergic to the study drug or belong to the susceptible population; ( 2 ) There are contraindications to general anesthesia; ( 3 ) Suffering from serious heart, cerebrovascular disease, respiratory disease, blood disease, endocrine disease or liver and kidney dysfunction; ( 4 ) Predictable difficult airway ( Mallampati grade III or IV ) or high risk factors for difficult laryngoscope exposure and difficult intubation: cervical disease, tooth abnormality, small jaw, mouth opening < 3 fingers, sleep apnea syndrome and snoring history, upper respiratory disease symptoms, subglottic stenosis, thyroid or tonsil enlargement, mediastinal mass, throat tumor, etc.; ( 5 ) Surgery or use of experimental drugs within one week before surgery; ( 6 ) Communication disorders, including reading and writing Chinese barriers, language barrier, visual impairment or hearing impairment.

Design outcomes

Primary

MeasureTime frame
Reaction during tracheal intubation;

Secondary

MeasureTime frame
The incidence of propofol injection pain;Induction period cough incidence rate;The incidence of coughing during awakening;Pain score;Wake-up time;Adverse reaction incidence rate;

Countries

China

Contacts

Public ContactHe Keyu

Chongqing University Fuling Hospital

569682851@qq.com+86 138 9657 3523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026